Fruselva, together with Ingredalia, the University of Barcelona (UB) and the University of the Balearic Islands (UIB), continues to advance in the FARO-i project, focused on the development of innovative and healthy products that contribute to the prevention of childhood obesity.
The research led by Fruselva has included an exhaustive systematic review of the scientific literature in several reference databases, selecting only high quality studies to guide future animal and human trials. All those studies that did not meet the quality criteria established by the consortium were eliminated, discarding for example animal trials with methodological limitations, studies that were not clinical trials and articles focused on other pathologies, which although related to obesity were not the object of study in FARO-i. The project is progressing satisfactorily and the results obtained will be published soon, contributing to global progress in the field of childhood obesity. These results may contribute to the advancement of other R&D projects focused on the fight against childhood obesity, thus accelerating research in this field.
Ingredalia, for its part, has led the selection of ingredients and by-products available to the consortium, prioritizing the application of the Circular Economy within the framework of the project. At the same time, intervention trials are being prepared at the UB to observe how the new developments elaborated by Fruselva work. Depending on the results obtained, the clinical trial designed by the UIB will start next year in the Balearic Islands.
The FARO-i project is a consortium that brings together the basic research groups of nutritional signaling (NCS) of the University of Barcelona and the NUCOX group of the University of the Balearic Islands. This collaboration ensures that each of the selected ingredients is backed by a solid scientific basis. Thanks to this comprehensive approach, intervention trials can be advanced, with the confidence that the products developed have the potential to improve metabolic health from an early age.